Home > Financial Ratios > TTK HEALTHCARE

TTK HEALTHCARE
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for TTK HEALTHCARE
Please provide your vote to see the results

TTK HEALTHCARE Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 25.42108.7630.47-21.08-35.31

What is the latest Core EBITDA Growth ratio of TTK HEALTHCARE ?

The latest Core EBITDA Growth ratio of TTK HEALTHCARE is 25.42 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202425.42
Mar2023108.76
Mar202230.47
Mar2021-21.08
Mar2020-35.31

How is Core EBITDA Growth of TTK HEALTHCARE Trending?

Years Core EBITDA Growth % Change
Mar2024 25.42
-76.63
Mar2023 108.76
256.94
Mar2022 30.47
Positive
Mar2021 -21.08
Negative
Mar2020 -35.31 -

Other Financial Ratios of TTK HEALTHCARE


Compare Core EBITDA Growth ratio of peers of TTK HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TTK HEALTHCARE ₹1,857.0 Cr -0.2% -9% -7.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,050.0 Cr 2.7% 0.9% 34.7% Stock Analytics
DIVIS LABORATORIES ₹155,208.0 Cr -1.1% 1.1% 57.7% Stock Analytics
CIPLA ₹117,197.0 Cr 0.6% -1.7% 8.4% Stock Analytics
DR REDDYS LABORATORIES ₹107,586.0 Cr -1.6% -4.6% 14.3% Stock Analytics
ZYDUS LIFESCIENCES ₹99,496.4 Cr -0.5% 2.5% 36% Stock Analytics


TTK HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

-0.2%

-9%

-7.8%

SENSEX

-0.7%

-2.6%

7.5%


You may also like the below Video Courses